Inadequate Regulation Contributes to Mislabeled Online Cannabidiol Products

Researchers from the University of Pennsylvania, Veterans Affairs San Diego, RTI international, Americans for Safe Access, Palo Alto University and Johns Hopkins University analyzed the content of 84 cannabidiol (CBD) products purchased on the internet and compared the results to their advertised co...

Descripción completa

Detalles Bibliográficos
Autores principales: Freedman, Daniel A., Patel, Anup D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pediatric Neurology Briefs Publishers 2018
Materias:
Antiepileptic Medications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024459/
https://www.ncbi.nlm.nih.gov/pubmed/30008541
http://dx.doi.org/10.15844/pedneurbriefs-32-3
_version_ 1783336058351517696
author Freedman, Daniel A.
Patel, Anup D.
author_facet Freedman, Daniel A.
Patel, Anup D.
author_sort Freedman, Daniel A.
collection PubMed
description Researchers from the University of Pennsylvania, Veterans Affairs San Diego, RTI international, Americans for Safe Access, Palo Alto University and Johns Hopkins University analyzed the content of 84 cannabidiol (CBD) products purchased on the internet and compared the results to their advertised concentrations.
format Online
Article
Text
id pubmed-6024459
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Pediatric Neurology Briefs Publishers
record_format MEDLINE/PubMed
spelling pubmed-60244592018-07-13 Inadequate Regulation Contributes to Mislabeled Online Cannabidiol Products Freedman, Daniel A. Patel, Anup D. Pediatr Neurol Briefs Antiepileptic Medications Researchers from the University of Pennsylvania, Veterans Affairs San Diego, RTI international, Americans for Safe Access, Palo Alto University and Johns Hopkins University analyzed the content of 84 cannabidiol (CBD) products purchased on the internet and compared the results to their advertised concentrations. Pediatric Neurology Briefs Publishers 2018-06-18 /pmc/articles/PMC6024459/ /pubmed/30008541 http://dx.doi.org/10.15844/pedneurbriefs-32-3 Text en Copyright: © 2018 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Antiepileptic Medications
Freedman, Daniel A.
Patel, Anup D.
Inadequate Regulation Contributes to Mislabeled Online Cannabidiol Products
title Inadequate Regulation Contributes to Mislabeled Online Cannabidiol Products
title_full Inadequate Regulation Contributes to Mislabeled Online Cannabidiol Products
title_fullStr Inadequate Regulation Contributes to Mislabeled Online Cannabidiol Products
title_full_unstemmed Inadequate Regulation Contributes to Mislabeled Online Cannabidiol Products
title_short Inadequate Regulation Contributes to Mislabeled Online Cannabidiol Products
title_sort inadequate regulation contributes to mislabeled online cannabidiol products
topic Antiepileptic Medications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024459/
https://www.ncbi.nlm.nih.gov/pubmed/30008541
http://dx.doi.org/10.15844/pedneurbriefs-32-3
work_keys_str_mv AT freedmandaniela inadequateregulationcontributestomislabeledonlinecannabidiolproducts
AT patelanupd inadequateregulationcontributestomislabeledonlinecannabidiolproducts

Ejemplares similares